Previous 10 | Next 10 |
Merger would create a clinical-stage cell therapy company AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and cell regeneration, and LyGenesis, Inc. (“LyGenesis”), a privately h...
Brisbane, Australia (ABN Newswire) - Alligator Energy (ASX:AGE) has today commenced its first planned exploration work on the Samphire Uranium Project near Whyalla, South Australia. Alligator completed the acquisition of Samphire in October 2020. Historic geophysical data acquired by Samp...
Brisbane, Australia (ABN Newswire) - Alligator Energy Limited (ASX:AGE) is pleased to release the 31 December 2020 Quarterly Report. Uranium - Completion of Samphire Project acquisition in South Australia - addition of a 47Mlb U3O8 resource (Refer ASX announcement: 8 Oct 2020) - A...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...
AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE) announced today that due to state and county government health orders, attendance at the AgeX 2020 Annual Meeting of Stockholders (the “Annual Meeting”) to be held at 10:00 a.m. Pacific Standard Time on Mon...
Brisbane, Australia (ABN Newswire) - Alligator Energy Limited (ASX:AGE) is pleased to advise that it has received firm commitments for a placement of $1.6M of fully paid ordinary shares to sophisticated and professional investors (Placement). The Placement, for which 180 Markets is the Lead M...
Brisbane, Australia (ABN Newswire) - Alligator Energy (ASX:AGE) is pleased to announce results from an initial Samphire Project desktop study commissioned through Inception Consulting Engineers (ICE). A full review of the exploration potential has also been conducted by AGE's internal explora...
Sublicensed stem cell line ESI-053 to ImStem Biotechnology for development of cell therapy candidate IMS001 for COVID-19 and acute respiratory distress syndrome from other causes. Expanded agreement related to ESI clinical-grade pluripotent stem cell lines to provide AgeX in...
Socket Mobile (SCKT) +42% as its S550 contactless reader achieves Apple wallet compatibility.AgeX Therapeutics (AGE) +16%.First Solar (FSLR) +12% on Q3 results.Tupperware Brands (TUP) +11% on Q3 results.Scholar Rock Holding (SRRK) +10%.XpresSpa Group (XSPA)&...
AgeX Therapeutics (AGE) shares jump 12% higher in premarket on light volume, after AgeX sublicensed embryonic stem cell line ESI-053, to ImStem to derive an investigational mesenchymal stem cell product candidate (IMS001) for development in COVID-19 as well ...
News, Short Squeeze, Breakout and More Instantly...
Shares of Serina to commence trading on NYSE American under the ticker symbol “SER” on March 27, 2024 Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024; IND submission to the FDA for the initiation of a Phas...
ALAMEDA, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for fourth quarter and the full year ended Decembe...
A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...